Ravisud Tablet
Tripotassium Bismuth Dicitrate 200mg · Ranitidine Hydrochloride 168mg +1 more
Tablet · Prescription medication · Combination
DaeWooong Bio Co., Ltd.
MFDS item code 201500623 · Approved 2015.02.05
This product's status changed to Expired on 2025.02.05. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related diseases (such as ulcers, gastritis, and gastroesophageal reflux disease) and prevention of Mendelson's syndrome
This medication is used for gastrointestinal diseases such as ulcers in the stomach and duodenum, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson's syndrome before anesthesia and is effective for treating postoperative ulcers. It is used for the treatment of gastric or duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). This medication helps improve symptoms and supports the healing of ulcers by inhibiting gastric acid secretion.
The usual dose is 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 2 tablets twice daily, in the morning and at bedtime. The same dose applies to ulcers caused by nonsteroidal anti-inflammatory drugs or to combination therapy for prevention of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and other conditions usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 1 tablet twice daily for 8 weeks or 2 tablets once daily at bedtime. In patients with severe reflux esophagitis, the dose may be increased to 2 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 1 tablet 3 times daily and increase the dose if necessary. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 1 tablet twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is also preferable to administer 1 tablet on the night before surgery.
This medication should not be administered to patients undergoing dialysis treatment. Patients who have had an allergic reaction to this medication or its components should not use it. This medication should not be given to patients with a specific condition known as acute porphyria, as it may exacerbate symptoms. Patients with poor kidney function or kidney disorders should use this medication with caution. Patients who have had gastrointestinal surgery or women who are pregnant or may become pregnant should not take this medication. This medication is not suitable for premature infants or newborns. Patients on a potassium-restricted diet should also avoid this medication. Patients with compromised liver function, a history of drug allergies, elderly patients, and those with a history of kidney disorders should use this medication carefully. Caution is especially necessary when used concurrently with non-steroidal anti-inflammatory drugs, and regular check-ups are recommended. This medication may mask symptoms of gastric cancer, so patients with gastric ulcers or new dyspeptic symptoms in middle age should confirm the malignancy before use. Patients with Helicobacter pylori infection and gastric or duodenal ulcers should also undergo treatment to eliminate the bacteria. Close attention is required for severely ill patients in intensive care, patients with hypophosphatemia, or those with swallowing difficulties when using this medication. Rarely, serious allergic reactions like anaphylactic shock may occur during the use of this medication; if symptoms arise, administration should be halted immediately and medical consultation sought. If allergic reactions such as skin rash, urticaria, or difficulty breathing occur, the medication should be discontinued. Blood tests may show decreases in white blood cells or platelets, so abnormal symptoms should prompt testing and possible cessation of administration. Symptoms of liver dysfunction may appear, so if jaundice or fatigue occurs, consult a physician immediately. Cardiovascular side effects like arrhythmias or vasculitis may occur rarely, so caution is necessary. Gastrointestinal symptoms such as nausea, vomiting, constipation, or diarrhea may occur, and stool color changes may also be seen, but this is not usually a condition requiring treatment. Neurological symptoms such as dizziness, drowsiness, confusion, and headache may occur rarely, and if any of these occur, use should be stopped. Gynecomastia, erectile dysfunction, and other symptoms have been reported very rarely, but causation is not clearly established. If muscle pain or joint pain occurs, the administration of this medication should be stopped and medical consultation sought. Skin rash or hair loss may occur sporadically; please inform your healthcare provider if any abnormal symptoms arise. Long-term use of this medication is not recommended, and if there is no therapeutic effect, it should be switched to another medicine. Elderly patients or those with chronic diseases may have an increased risk of pneumonia, so caution is required. If dizziness or drowsiness occurs during use, avoid driving or operating dangerous machinery. There may be interactions with other medications, so make sure to inform your healthcare provider of any medications you are currently taking. It is safest for pregnant or breastfeeding women not to use this medication. Safety for children has not been established, so it is advisable not to administer this medication to children. This medication may cause false positive reactions during urine protein tests, so caution is advised during testing. In case of overdose, treatments like vomiting or gastric lavage may be necessary, and in severe cases, blood dialysis may be required. This medication reduces gastric acid secretion, which may promote bacterial growth in the gastrointestinal tract; therefore, regular check-ups, including eye examinations, are recommended during long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature to preserve its efficacy.
Light green rectangular film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Tripotassium Bismuth Dicitrate 200mg · Ranitidine Hydrochloride 168mg +1 more
Tablet · Prescription medication · Combination
DaeWooong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.